Journal of Endocrinological Investigation

, Volume 24, Issue 3, pp 183–187 | Cite as

Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases

  • P. Cappabianca
  • S. Lodrini
  • G. Felisati
  • C. Peca
  • R. Cozzi
  • A. Di Sarno
  • L. M. Cavallo
  • S. Giombini
  • A. Colao
Case Report


Three cases of cerebrospinal fluid (CSF) leak, in subjects with an invasive macroprolactinoma under treatment with cabergoline (CAB), are reported. The patients underwent surgical treatment by means of an endoscopic endonasal transsphenoidal approach, which allowed removal of the lesion and sealing of the fistula. Many cases of CSF rhinorrhea are described in literature after bromocriptine therapy in invasive prolactinomas, but only one report has been recently published of such condition after CAB treatment. The complication is likely due to the brisk cessation of the so-called “stopper effect”, i.e. the tumor mechanically blocking the CSF leak in spite of its previous erosion of the skull-base, when CAB induces the macroprolactinoma shrinkage. Endoscopic transsphenoidal surgery offers a safe, minimally invasive and efficient management of this complication, which allows to regularly perform the following steps of the therapeutical strategy against the prolactinoma.


Cabergoline CSF rhinorrhea endoscopy pituitary adenoma prolactinoma transsphenoidal surgery 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Colao A., Annunziato L., Lombardi G. Treatment of prolactinomas. Ann. Med. 1998, 30: 452–459.PubMedCrossRefGoogle Scholar
  2. 2.
    Webster J., Piscitelli G., Polli A., Ferrari C.I., Ismail I., Scanlon M.F. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N. Engl. J. Med. 1994, 331: 904–909.PubMedCrossRefGoogle Scholar
  3. 3.
    Molitch M.E. Medical treatment of prolactinomas. Endocrinol. Metab. Clin. North Am. 1999, 28: 143–169.PubMedCrossRefGoogle Scholar
  4. 4.
    Colao A., Di Sarno A., Landi M.L., Cirillo S., Sarnacchiaro F., Facciolli G., Pivonello R., Cataldi M., Merola B., Annunziato L., Lombardi G. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J. Clin. Endocrinol. Metab. 1997, 82: 3574–3579.PubMedCrossRefGoogle Scholar
  5. 5.
    Ferrari C.I., Abs R., Bevan J.S., Brabant G., Ciccarelli E., Motta T., Mucci M., Muratori M., Musatti L., Verbessem G., Scanlon M.F. Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin. Endocrinol. (Oxf.) 1997, 46: 409–413.CrossRefGoogle Scholar
  6. 6.
    Carroll W.R., Cohen S., Sullivan M.J. Spontaneous CSF rhinorrhea: an unusual presentation of a pituitary adenoma. Otolaryngol. Head Neck Surg. 1991, 104: 380–383.PubMedGoogle Scholar
  7. 7.
    Obana W.G., Hodes J.E., Weinstein P.R., Wilson C.B. Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenoma: report of two cases. Surg. Neurol. 1990, 33: 336–340.PubMedCrossRefGoogle Scholar
  8. 8.
    Spaziante R., Corriero G., Cappabianca P., Russo A., Donzelli R., Irace C., Carrabs G. Rinoliquorrea rivelatrice di un adenoma ipofisario invasivo associato ad empty sella. Caso clinico. Quad. Med. Chir. 1987, 3: 1–6.Google Scholar
  9. 9.
    Aronoff S.L., Daughaday W.H., Laws E.R. Jr. Bromocriptine treatment of prolactinomas. N. Engl. J. Med. 1979, 300: 1391 (letter).PubMedCrossRefGoogle Scholar
  10. 10.
    Barlas O., Bayindir C., Hepgul K., Can M., Kiris T., Sencer E., Unal F., Aral F. Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature. Surg. Neurol. 1994, 41: 486–489.PubMedCrossRefGoogle Scholar
  11. 11.
    Baskin D.S., Wilson C.B. CSF rhinorrhea after bromocriptine for prolactinoma. N. Engl. J. Med. 1982, 306: 178.PubMedGoogle Scholar
  12. 12.
    Bronstein M.D., Musolino N.R., Benabou S., Marino R. Cerebropinal fluid rhinorrhea occurring in longterm bromocriptine treatment for macroprolactinomas. Surg. Neurol. 1989, 32: 346–349.PubMedCrossRefGoogle Scholar
  13. 13.
    Hildebrandt G., Zierski J., Christophis P., Laun A., Schatz H., Lancranjan I., Klug N. Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma. Acta Neurochir. (Wien) 1989, 96: 107–113.CrossRefGoogle Scholar
  14. 14.
    Holness R.O., Shlossberg A.H., Heffernan L.P. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma. Neurology 1984, 34: 111–113.PubMedCrossRefGoogle Scholar
  15. 15.
    Pascal-Vigneron V., Weryha G., Braun M., Morel-Jean J., Bisset S., Leclère J. La rhinorrhée et l’otorrhée: des complications rares du traitement médical del prolactinomes invasifs. Ann. Endocrinol. (Paris) 1993, 54: 347–351.Google Scholar
  16. 16.
    Jho H.D., Carrau R. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J. Neurosurg. 1997, 87: 44–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Cappabianca P., Alfieri A., de Divitiis E. Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS). Min. Invas. Neurosurg. 1998, 41: 66–73.CrossRefGoogle Scholar
  18. 18.
    Rothrock J.F., Laguna J.F., Reynolds A.F. Rhinorrhea from untreated pituitary adenoma. Arch. Neurol. 1982, 39: 442–443.PubMedCrossRefGoogle Scholar
  19. 19.
    Nutkiewicz A., De Feo D.R., Kohut R.I., Fierstien S. Cerebrospinal fluid rhinorrhea as a presentation of pituitary adenoma. Neurosurgery 1980, 6: 195–197.PubMedCrossRefGoogle Scholar
  20. 20.
    Spaziante R., de Divitiis E. Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenomas. Surg. Neurol. 1991, 36: 150–151.PubMedCrossRefGoogle Scholar
  21. 21.
    Leong K.S., Foy P.M., Swift A.C., Atkin S.L., Hadden D.R., MacFarlane I.A. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin. Endocrinol. (Oxf.) 2000, 52: 43–49.CrossRefGoogle Scholar
  22. 22.
    Fager C.A. Nature and treatment of cerebrospinal fluid rhinorrhea in pituitary tumors. Surg. Clin. North Am. 1973, 53: 283–290.PubMedGoogle Scholar
  23. 23.
    Pellegrini I., Rasolonjanahary R., Gunz G., Bertrand P., Delivet S., Jedynak C.P., Kordon C., Peillon F., Jaquet P., Enjalbert A. Resistance to bromocriptine in prolactinomas. J. Clin. Endocrinol. Metab. 1989, 69: 500–509.PubMedCrossRefGoogle Scholar
  24. 24.
    Ciccarelli E., Grottoli S., Razzore P., Gaia D., Bertagna A., Cirillo S., Cammarota T., Camanni M., Camanni F. Long-term treatment with cabergoline, a new longlasting ergoline derivative in idiopathic or tumorous hyperprolactinemia and outcome of drug-induced pregnancy. J. Endocrinol. Invest. 1997, 20: 547–551.PubMedGoogle Scholar
  25. 25.
    Colao A., Di Sarno A., Landi M.L., Scavuzzo F., Cappabianca P., Pivonello R., Volpe R., Di Salle F., Cirillo S., Annunziato L., Lombardi G. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pre-treated with other dopamine agonists: a prospective study in 110 patients. J. Clin. Endocrinol. Metab. 2000, 85: 2247–2252.PubMedGoogle Scholar
  26. 26.
    Colao A., Di Sarno A., Sarnacchiaro F., Ferone D., Di Renzo G., Merola B., Annunziato L., Lombardi G. Prolactinomas resistant to other dopamine agonists respond to chronic cabergoline treatment. J. Clin. Endocrinol. Metab. 1997, 83: 876–883.CrossRefGoogle Scholar
  27. 27.
    Verhelst J., Abs R., Maiter D., van den Bruel A., Vandeweghe M., Velkeniers B., Mockel J., Lamberigts G., Petrossians P., Coremans P., Mahler C., Stevenaert A., Verlooy J., Raftopoulos C., Beckers A. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J. Clin. Endocrinol. Metab. 1999, 84: 2518–2522.PubMedCrossRefGoogle Scholar
  28. 28.
    Kennedy D.W. Functional endoscopic sinus surgery. Technique. Arch. Otolaryngol. 1985, 111: 643–649.CrossRefGoogle Scholar
  29. 29.
    Wigand M.E. Transnasal ethmoidectomy under endoscopic control. Rhinology 1981, 19: 7–15.PubMedGoogle Scholar
  30. 30.
    Cappabianca P., Alfireri A., Colao A., Ferone D., Lombardi G., de Divitiis E. Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg. 1999, 9: 109–117.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2001

Authors and Affiliations

  • P. Cappabianca
    • 1
  • S. Lodrini
    • 3
  • G. Felisati
    • 4
  • C. Peca
    • 1
  • R. Cozzi
    • 5
  • A. Di Sarno
    • 2
  • L. M. Cavallo
    • 1
  • S. Giombini
    • 3
  • A. Colao
    • 2
  1. 1.Departimento di NeurochirurgiaUniversità “Federico II”NaplesItaly
  2. 2.Department of Clinical and Molecular Endocrinology and Oncology“Federico II” UniversityNaplesItaly
  3. 3.Department of Neurosurgery, Istituto Neurologico “C. Besta”University of MilanMilanItaly
  4. 4.Department of Otorhinolaryngology, Istituti Clinici di PerfezionamentoUniversity of MilanMilanItaly
  5. 5.Department of EndocrinologyOspedale Maggiore “Cà Granda”MilanItaly

Personalised recommendations